• Azathramycin A: Macrolide Antibiotic Workflows for TB Models

  2026-05-22

  Azathramycin A delivers targeted inhibition of Mycobacterium tuberculosis ribosomes, enabling high-fidelity studies of protein synthesis inhibition and antibiotic resistance. This guide details best practices, advanced applications, and troubleshooting strategies to maximize reproducibility and impact in tuberculosis research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-05-22

  This multicenter study dissects the molecular epidemiology and plasmid-mediated transmission of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong, China. Robust experimental design reveals the dominance of blaNDM-1, the high frequency of horizontal gene transfer, and significant multidrug resistance, offering actionable insights for antimicrobial resistance surveillance and research.

• Alda 1: ALDH2 Activator Protocols for Cardiac Regeneration

  2026-05-21

  Alda 1, a robust ALDH2 activator from APExBIO, empowers researchers to extend cardiomyocyte proliferation and enhance cardiac protection in ischemia and radiation models. This guide translates the latest bench findings into actionable workflows and troubleshooting strategies to maximize reliability and scientific impact.

• Busulfan as a DNA Alkylating Agent: Applied Workflows & Insi

  2026-05-21

  Busulfan, a powerful DNA alkylating agent, is indispensable for modeling germ cell depletion and cellular senescence in both cell culture and animal studies. This article delivers actionable protocols, advanced troubleshooting, and key insights from recent genetic tracing breakthroughs, all grounded in the rigor of APExBIO-supplied Busulfan.

• DMG-PEG2000-NH2: Optimizing NH2-PEG Derivative Workflows in

  2026-05-20

  DMG-PEG2000-NH2 stands out as a high-purity NH2-PEG derivative, streamlining amide bond formation for lipid-based drug delivery with exceptional solubility and biocompatibility. This guide provides actionable protocols, troubleshooting tips, and experimental insights to maximize encapsulation efficiency for siRNA, proteins, and advanced antimicrobials.

• p53/PUMA-Mediated Synthetic Lethality via WRN Inhibition in

  2026-05-20

  The reference study clarifies the molecular mechanism underlying synthetic lethality in mismatch repair-deficient (MSI) colorectal cancer by showing that WRN helicase inhibition triggers p53 and PUMA-dependent apoptosis. These findings establish WRN as a promising therapeutic target in p53-wildtype MSI CRC and provide a mechanistic rationale for further research into DNA repair enzyme inhibitors in cancer therapy.

• NLRP10 Regulates Keratinocyte Survival and Skin Barrier in A

  2026-05-19

  This study demonstrates that NLRP10 is a central regulator of epidermal homeostasis, supporting keratinocyte survival and P63-dependent differentiation, which are essential for maintaining skin barrier integrity in atopic dermatitis (AD). The findings provide mechanistic insight into how genetic variation at the NLRP10 locus contributes to AD pathogenesis and underscore NLRP10 as a potential therapeutic target for restoring epidermal function.

• Nonivamide: Capsaicin Analog for Cancer & Neuroimmune Assays

  2026-05-19

  Leverage Nonivamide, a selective TRPV1 agonist, to unlock robust anti-proliferative and neuroimmune workflows. This guide details stepwise protocols, cross-model troubleshooting, and practical insights directly informed by the latest reference breakthroughs.

• FLT3–TAZ Axis Drives Drug Resistance in BP-CML: New Insights

  2026-05-18

  Shin et al. (2023) redefined the role of FLT3 signaling in blast phase chronic myeloid leukemia (BP-CML), uncovering a distinct FLT3+ subgroup with poor prognosis and resistance to BCR::ABL1 TKIs. Their multi-omics approach demonstrated that targeting FLT3, particularly in combination with existing therapies, can overcome resistance mechanisms and improve therapeutic outcomes.

• Fosinopril Sodium: Integrative Pharmacology for Cardiovascul

  2026-05-18

  Explore the advanced pharmacology of Fosinopril sodium as a potent ACE inhibitor. This article provides a unique, mechanism-driven analysis for cardiovascular disease research, emphasizing renal hemodynamics and translational assay design.

• Organic Cation Transporter Response to Olsalazine in Aedes a

  2026-05-17

  Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes physiologically process xenobiotic dyes, including the mesalamine dimer Olsalazine Sodium, focusing on excretion profiles and transporter gene expression. Their findings highlight the structural dependence of xenobiotic clearance and mortality, providing a foundation for targeting transporter mechanisms in mosquito vector control strategies.

• Phosbind Acrylamide: Transforming Phosphorylation SDS-PAGE D

  2026-05-16

  Phos binding reagent (Phosbind) acrylamide enables fast, antibody-free protein phosphorylation analysis directly during SDS-PAGE, overcoming bottlenecks of traditional phospho-protein detection. Its workflow-centric design allows for precise, reproducible mobility shift assays in signaling research—especially for complex stress response pathways.

• BIBP 3226 trifluoroacetate: Precision Dissection of the Adip

  2026-05-15

  Unlocking the role of BIBP 3226 trifluoroacetate in adipose-neural axis research, this article explores its advanced application for dissecting NPY/NPFF signaling in cardiovascular and neurobiological contexts. Discover nuanced assay design guidance and translational insights beyond conventional protocols.

• EPZ-6438: Advanced EZH2 Inhibitor Workflows in Cancer Resear

  2026-05-15

  EPZ-6438 enables precise, reproducible modulation of the polycomb repressive complex 2 (PRC2) pathway for epigenetic cancer research. This article details stepwise experimental design, troubleshooting strategies, and highlights novel applications in HPV-associated cervical cancer models.

• Mianserin HCl: Optimizing 5-HT2 Antagonist Workflows in Rese

  2026-05-14

  Mianserin HCl enables precise modulation of serotonin receptor pathways, with proven advantages in both psychiatric disorder models and emerging antipathogenic assays. This article details evidence-backed protocols, troubleshooting strategies, and advanced workflow enhancements that unlock the full research value of this distinctive 5-HT2 receptor antagonist.

15920 records 1/1062 page Next 12345 下5页 Last page